Litcius/Paper detail

Rational design of phenyl 2,4,5-trichlorobenzenesulfonate based thiosemicarbazones as α-glucosidase and α-amylase inhibitors: integrating enzymatic evaluation and molecular modeling

Faiqa Noreen, Magdi E. A. Zaki, Nastaran Sadeghian, Feyzi Sinan Tokalı, Parham Taslımı, Rima D. Alharthy, Halil Şenol, Xianliang Zhao, Furkan Çakır, Sobhi M. Gomha, Zahid Shafiq

2026RSC Advances5 citationsDOIOpen Access PDF

Abstract

findings highlight compound 16 as a promising lead candidate for further optimization and development as a dual α-Glu and α-Amy inhibitor for the management of type 2 diabetes mellitus.

Topics & Concepts

ChemistryADMEMolecular modelRational designCombinatorial chemistryLead compoundMolecular dynamicsSemicarbazoneDrug designStereochemistryEnzymeComputational chemistryDocking (animal)Molecular conformationLipinski's rule of fivevan der Waals forceAcarboseActive siteMolecular bindingPharmacokineticsLigand (biochemistry)Drug candidateHomology modelingLigand efficiencyMetabolic stabilityStructure–activity relationshipDrug discoveryMoleculeMolecular mechanicsNatural Antidiabetic Agents StudiesEnzyme Production and CharacterizationCarbohydrate Chemistry and Synthesis
Rational design of phenyl 2,4,5-trichlorobenzenesulfonate based thiosemicarbazones as α-glucosidase and α-amylase inhibitors: integrating enzymatic evaluation and molecular modeling | Litcius